Generic Drugs

Generic Drugs News

India pledges $15-mn at virtual global vaccine summit; funds to be used for immunisation programmes across the world
World

India pledges $15-mn at virtual global vaccine summit; funds to be used for immunisation programmes across the world

Prime Minister Narendra Modi on Thursday pledged $15-million as India's contribution to the vaccines alliance GAVI at the Global Vaccine Summit hosted by the UK

Budget 2020: Policy reforms, additional outlay only way to boost life science, healthcare and pharmaceutical industry
Business

Budget 2020: Policy reforms, additional outlay only way to boost life science, healthcare and pharmaceutical industry

Given the ambition of the government to make India a $5 trillion economy in the next five years, pharmaceutical and life science could be the ‘Target sector’ in Budget 2020 for reforms,

Pfizer in talks to merge off-patent drugs business with Mylan in a stock deal; plans to form global generic drug giant: Report
Business

Pfizer in talks to merge off-patent drugs business with Mylan in a stock deal; plans to form global generic drug giant: Report

Pfizer Inc plans to combine its off-patent business, which includes Lipitor cholesterol pills and male impotence drug Viagra, with Mylan NV

US-China trade war: Beijing opens to Indian pharma companies as it looks for new commercial partners
Business

US-China trade war: Beijing opens to Indian pharma companies as it looks for new commercial partners

Swift regulatory approvals in China would allow Indian companies to boost revenue at a time when pricing scrutiny and regulatory troubles have hurt US sales

Narendra Modi in London: PM's remarks on doctors rile medicos, but studies confirm high costs ail India's healthcare
India

Narendra Modi in London: PM's remarks on doctors rile medicos, but studies confirm high costs ail India's healthcare

Narendra Modi's remarks in London on doctors have evoked much outrage. However, several studies indicate that this anger is not justified.

Uttar Pradesh to become second state after Karnataka to have state-specific health policy
India

Uttar Pradesh to become second state after Karnataka to have state-specific health policy

UP government is in the process of finalising the state's first-ever state health policy and it is likely to be notified in the next three months.

New pharma policy will make drugs cheaper but accessibility remains a concern
India

New pharma policy will make drugs cheaper but accessibility remains a concern

According to the newly proposed draft national pharmaceutical policy, the government plans to cap trade margins to make drugs cheaper, replace brand names with names of salts or generic drugs, clamp down on unfair marketing practices and give a boost to local manufacturing to reduce dependence on imports.

Generic versions for Hepatitis C treatment cost-effective in terms of life expectancy: Study
India

Generic versions for Hepatitis C treatment cost-effective in terms of life expectancy: Study

About 71 million people are estimated to be affected with chronic Hepatitis C infection globally and of them six to 11 million are estimated to be in India

Why branded drugs cost way more than their generic counterparts
India

Why branded drugs cost way more than their generic counterparts

The medicines available in the market then were all branded and each manufacturer of medicine had their own way to prepare a certain drug.

Dr Reddy's shares hit near three-year low, drops 4% as Duvvada unit receives 13 observations from US FDA
Business

Dr Reddy's shares hit near three-year low, drops 4% as Duvvada unit receives 13 observations from US FDA

The Duvvuda unit makes cytotoxic and hormonal injectables. It is an important unit for Dr Reddy’s

India at WTO: Takes strong stand to save generic drugs industry, calls for transparent health assessment
World

India at WTO: Takes strong stand to save generic drugs industry, calls for transparent health assessment

Governments engaged in bilateral and regional trade investments should ensure that these agreements do not include provisions that impinge on the right to health, India said in a strong statement delivered at the WTO highlighting a longstanding fight by India to sustain its generic drugs industry.

Six Indian pharma companies get new licences to supply generic drugs
World

Six Indian pharma companies get new licences to supply generic drugs

The UN-backed Medicines Patent Pool signed licences for the production of generic drugs.

At landmark BRICS meet, India raises public health, pharma sector concerns
World

At landmark BRICS meet, India raises public health, pharma sector concerns

India as the BRICS pres hosted a high level panel discussion on access to medicines and trade that was attended by all the health mins and deputy health mins of Brazil, China, Russia, India, South Africa and also Chile.

India, EU working to end trade dispute over generic drugs
Business

India, EU working to end trade dispute over generic drugs

The PMO wrote to the EU Trade Commissioner to intervene when the ban on around 700 pharmaceutical products was formalised in May, two government sources in New Delhi said.

Sun Pharma shells out $4 bn for Ranbaxy, becomes biggest Indian pharma firm
India

Sun Pharma shells out $4 bn for Ranbaxy, becomes biggest Indian pharma firm

The merged company will become the world's fifth-largest specialty generics company and the largest drug firm in India.

US FDA bans more products from Ranbaxy
Biztech

US FDA bans more products from Ranbaxy

The US Food and Drug Administration said on Thursday it has banned more products from drugmaker Ranbaxy Laboratories from entering the United States due to manufacturing violations.

FDA, European regulators to cooperate on generic drugs
World

FDA, European regulators to cooperate on generic drugs

US and European drug regulators will work together on joint inspections around the world to try to make sure consumers are buying generic medications that are both safe and effective, the US Food and Drug Administration said on Wednesday.

US FDA for greater freedom to generic drug firms
Business

US FDA for greater freedom to generic drug firms

US drug regulator Food and Drug Administration (FDA) plans to allow generic drug makers, including those from India, to independently update product labelling when they discover new safety data, a move which can bring them on par with branded medicine manufacturers.<br /><br />

CAG slams the govt for procurement of branded drugs
India

CAG slams the govt for procurement of branded drugs

An amount of Rs 11.81 crore could have been saved if generic drugs had been procured, said a CAG report which was tabled in Parliament on Friday.